tirzepatide glp 1 and gip Compound Tirzepatide for Medical Weight Loss

This helps you maintain muscle while supporting your metabolic health during weight loss

The SURMOUNT-1 trial enrolled 2,539 adults with obesity or overweight and demonstrated weight loss of 15 percent at the 5 mg dose, 19.5 percent at the 10 mg dose, and 20.9 percent at the 15 mg dose over 72 weeks

Clear communication about the rationale for weekly dosingmaintaining stable drug levels and optimizing therapeutic effectshelps patients appreciate the importance of adherence

Facelifts erase deep wrinkles and lift drooping skin, whereas alternatives such as eyelid surgery or fat grafting focus on targeted areas

Patients receive guidance on dose titration, management of common side effects like nausea or appetite suppression, and strategies to optimize results through nutrition and movement

When prescribed for weight loss, this constitutes off-label usea practice permitted under medical judgment but outside the FDA-approved indication